The round was co-led by Merck Animal Health, and Mountain Group Partners (MGP), with participation from Oval Park Capital.
The company intends to use the funds to accelerate the development of its system.
Led by Ramin Karimpour, Founder and CEO, ALSS integrates its proprietary technologies in high speed imaging, feature recognition, artificial intelligence, robotics & microfluidics in a system that can individually vaccinate up to 100,000 chicks per hour against diseases such as coccidiosis, infectious bronchitis and Newcastle.
FinSMEs
25/03/2019